Summary:
- This article discusses the development and testing of a new vaccine candidate against the SARS-CoV-2 virus, which causes COVID-19.
- The researchers used a novel approach involving a recombinant protein derived from the virus's spike protein, combined with an adjuvant to enhance the immune response.
- Clinical trials showed the vaccine candidate was safe and effective, providing strong protection against the virus, including variants of concern. This could be a promising new tool in the fight against the ongoing COVID-19 pandemic.